NCT02804269 Molecular and Imaging Studies of Cardiovascular Health and Disease
| NCT ID | NCT02804269 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Heart Centre Singapore |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2013-07 |
| Primary Completion | 2033-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2013-07 with a primary completion date of 2033-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Biobank is a program which collects biological samples, health information and imaging data from consented patients and stored them at the core facility. These information would be used to study the molecular, imaging and outcome studies of cardiovascular health and disease.
Eligibility Criteria
There is no inclusion/exclusion criteria except for the age limit as this is a repository program. Inclusion Criteria: •Subject aged ≥ 16 years and ≤ 90 years. Exclusion Criteria: •No
Contact & Investigator
Stuart Cook, MBBS,PhD
PRINCIPAL INVESTIGATOR
National Heart Centre Singapore
Frequently Asked Questions
Who can join the NCT02804269 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 90 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02804269 currently recruiting?
Yes, NCT02804269 is actively recruiting participants. Contact the research team at kong.siew.ching@nhcs.com.sg for enrollment information.
Where is the NCT02804269 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT02804269 clinical trial?
NCT02804269 is sponsored by National Heart Centre Singapore. The principal investigator is Stuart Cook, MBBS,PhD at National Heart Centre Singapore. The trial plans to enroll 5,000 participants.